It was reported that eIF4E is highly phosphorylated and overexpressed in some solid tumors, including NSCLC, prostate cancer, breast cancer, penile squamous cell carcinoma, where eIF4E phosphorylation correlates with poor survival and tumor progression7–9, 11. Here, EIF4E is linked to squamous cell carcinoma of penis.